Bryant, Maria http://orcid.org/0000-0001-7690-4098
Burton, Wendy
Collinson, Michelle
Farrin, Amanda
Nixon, Jane
Stevens, June
Roberts, Kim
Foy, Robbie
Rutter, Harry
Copsey, Bethan
Hartley, Suzanne
Tubeuf, Sandy
Brown, Julia
Funding for this research was provided by:
Research Trainees Coordinating Centre (CDF-2014-07-052)
Article History
Received: 23 January 2021
Accepted: 25 October 2021
First Online: 5 November 2021
Declarations
:
: The trial study was approved by the School of Medicine Research Ethics Committee at the University of Leeds (MREC15-017).
: Not applicable
: KR is the chief executive of HENRY, which may receive increased publicity and consequent commissioning as a result of this research. KR was blinded to treatment allocation and was excluded from steering committee meetings. Involvement of KR was essential for the development of the optimisation intervention under investigation (ensuring feasible approaches were recommended and agreeing on related incurred costs). At the time of the study, HR was supported by the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Barts Health NHS Trust. The other authors declare that they have no competing interests.